Presenting at the Femtech & Consumer Innovation Summit – New Jersey
Having easily had a thousand rejections (and counting) – but at the same time with some success including $5m+ in grants / non-dilutive funding – raising funding in the women’s health space is *NOT for the faint of heart* (and no matter how important and impactful an innovation is) 😳. I’m looking forward to sharing some …
Attending the FemTech Forward 2024 Conference
Team members Thang Vo-Ta and Kaylie Mings represented Calla Lily at the FemTech Conference held at University of Oxford. Besides Thang’s presentation on the progress of our Callavid drug delivery & Lilyvid sample collection technologies, there were also more personal sharings with the wider community at an innovation showcase held in the observatory building of …
Attending the Endometriosis Foundation of America Annual Blossom Ball
Our co-founder Dr. Lara Zibners was in New York to attend the Endometriosis Foundation of America Annual Blossom Ball. The exciting and impactful annual event included an important award to Drs Christine Metz and Peter K. Gregersen from The Feinstein Institutes Northwell Health for their ground breaking work in diagnosing endometriosis. A big congratulations to …
Attending the Women’s Health Innovation Summit Europe
As is always the case with the Women’s Health Innovation Series Summits, it was an invigorating and inspiring 2 days in Basel. Besides making new connections with small & large change-makers advancing womens health – it was also great to catch-up with existing collaborators: Brandi Howard, from Premier Research our regulatory/clinical trial advisors. Professor Joyce …
Attending the Inaugral Microbes in Women’s Health Congress
Our Principal Scientist Andrew Lewis and Co-Founder Thang Vo-Ta recently took part in the inaugural Microbes in Women’s Health Congress in Copenhagen! They attended superb seminars/presentations, had great catch-ups and forged new & important connections in the groundbreaking microbiome space. The unfolding science is getting undeniable: reproductive tract dysbiosis or the lack of a healthy …
Attending the Launch of Tommy’s National Centre for Preterm Birth Research
It was wonderful for members of our team to celebrate Tommy’s launch of their amazing new preterm birth centre. Always energising and inspiring to be in a room full of clinicians, researchers, midwives, engineers, supporters, and those with lived experience – for such an important cause. We are excited about how impactful our Callavid device will …
Presenting at the Inclusivity in Women’s Health Tech Event
Congratulations to our colleague Dr Serena de Gelidi and our collaborators at UCL School Of Pharmacy Catherine Tuleu and Scheilly Tsilova on their well received presentation at the Inclusivity in Women’s Health Tech event held at the Royal College of Physicians. We were delighted to share the results of our project “Supporting women needing vaginal progesterone: …
Attending the Medica 2023 Medical Trade Fair
Members of our team attended Medica 2023 in Dusseldorf, the world’s largest medical trade fair. It was great to meet up in person with our existing partners, but also to network and discover new exciting materials, suppliers and to create unique partnering opportunities.
Attending the LSX Investival Showcase
It was a busy start to kick-off Europe’s biggest dedicated healthcare investment week by taking part in the LSX – partnering for Life Science eXecutives Investival Showcase here in London. Always a privilege to be able to share Calla Lily Clinical Care‘s exciting progress with our drug delivery technology and to meet with several new …
Calla Lily at the Women’s Health Innovation Summit Boston
We had a brilliant time attending the Women’s Health Innovation Series Summit in Boston 🇺🇸 – we learned, engaged and got inspired by other passionate advocates dedicated to improving women’s health. And it was great to share CLCC’s progress and to connect with more potential partners and collaborators with our #drugdelivery platform for #fertility #menopause …